BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lim S, Kim JW, Targher G. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab 2021;32:500-14. [PMID: 33975804 DOI: 10.1016/j.tem.2021.04.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Jain S, Jacobson KA. Purinergic Signaling in Liver Pathophysiology. Front Endocrinol (Lausanne) 2021;12:718429. [PMID: 34456873 DOI: 10.3389/fendo.2021.718429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ahmed H, Umar MI, Imran S, Javaid F, Syed SK, Riaz R, Hassan W. TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. Exp Mol Pathol 2021;124:104733. [PMID: 34914973 DOI: 10.1016/j.yexmp.2021.104733] [Reference Citation Analysis]
3 Liu L, Xie S, Teng Y, Deng Z, Chen K, Liu H, Huo R, Liang X, Guo P, Yang D, Ma L, Xiang B, Li L, Zhong J. Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC. Front Oncol 2022;11:783339. [DOI: 10.3389/fonc.2021.783339] [Reference Citation Analysis]
4 Shea S, Lionis C, Kite C, Atkinson L, Chaggar SS, Randeva HS, Kyrou I. Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress. Biomedicines 2021;9:1697. [PMID: 34829926 DOI: 10.3390/biomedicines9111697] [Reference Citation Analysis]
5 Zhang B, Jiang M, Zhao J, Song Y, Du W, Shi J. The Mechanism Underlying the Influence of Indole-3-Propionic Acid: A Relevance to Metabolic Disorders. Front Endocrinol 2022;13:841703. [DOI: 10.3389/fendo.2022.841703] [Reference Citation Analysis]
6 Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol 2021:S0168-8278(21)01964-4. [PMID: 34380057 DOI: 10.1016/j.jhep.2021.07.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wang X, Liu X, He P, Guan K, Yang Y, Lei Y, Cai J, Wang W, Wu T, Rauf A. The Imbalance of Mitochondrial Homeostasis of Peripheral Blood-Derived Macrophages Mediated by MAFLD May Impair the Walking Ability of Elderly Patients with Osteopenia. Oxidative Medicine and Cellular Longevity 2022;2022:1-21. [DOI: 10.1155/2022/5210870] [Reference Citation Analysis]
8 Michels N, Zouiouich S, Vanderbauwhede B, Vanacker J, Indave Ruiz BI, Huybrechts I. Human microbiome and metabolic health: An overview of systematic reviews. Obes Rev 2022;:e13409. [PMID: 34978141 DOI: 10.1111/obr.13409] [Reference Citation Analysis]
9 Euh W, Lim S, Kim JW. Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:613389. [PMID: 34177796 DOI: 10.3389/fendo.2021.613389] [Reference Citation Analysis]
10 Zheng Q, Xue C, Gu X, Shan D, Chu Q, Wang J, Zhu H, Chen Z. Multi-Omics Characterizes the Effects and Mechanisms of CD1d in Nonalcoholic Fatty Liver Disease Development. Front Cell Dev Biol 2022;10:830702. [DOI: 10.3389/fcell.2022.830702] [Reference Citation Analysis]
11 Xu W, Zhou F, Zhu Q, Bai M, Luo T, Zhou L, Deng R. Calycosin-7-O-β-D-glucoside attenuates palmitate-induced lipid accumulation in hepatocytes through AMPK activation. Eur J Pharmacol 2022;:174988. [PMID: 35490724 DOI: 10.1016/j.ejphar.2022.174988] [Reference Citation Analysis]
12 Zhou W, Deng X, Zhu X, Yan Q, Zhou N, Du S, Li X. HtrA2/Omi mitigates NAFLD in high-fat-fed mice by ameliorating mitochondrial dysfunction and restoring autophagic flux. Cell Death Discov 2022;8:218. [PMID: 35449197 DOI: 10.1038/s41420-022-01022-4] [Reference Citation Analysis]
13 Zou Y, Li Q, Gao J, Pan J, Ma J, Chen L, Lin J, Mo Y, Zhang X, Liu P, Dai L. Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort. Front Cardiovasc Med 2022;9:884636. [DOI: 10.3389/fcvm.2022.884636] [Reference Citation Analysis]
14 Manolis AS, Manolis AA, Manolis TA, Apostolaki NE, Melita H. COVID-19 infection and body weight: A deleterious liaison in a J-curve relationship. Obes Res Clin Pract 2021;15:523-35. [PMID: 34799284 DOI: 10.1016/j.orcp.2021.10.006] [Reference Citation Analysis]
15 Giudetti AM, Vergara D, Longo S, Friuli M, Eramo B, Tacconi S, Fidaleo M, Dini L, Romano A, Gaetani S. Oleoylethanolamide Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in High-Fat Diet-Fed Rats. Antioxidants (Basel) 2021;10:1289. [PMID: 34439537 DOI: 10.3390/antiox10081289] [Reference Citation Analysis]